• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MVP
Click for more information
0.00% 45.0¢

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED - News & Media

Market Cap $38.83M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Medical Developments International Limited is an Australia-based company that delivers... Medical Developments International Limited is an Australia-based company that delivers emergency medical solutions dedicated to improving patient outcomes in both domestic and international markets. The Company operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The Company manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.More

Articles & Videos

Medical Developments International (ASX:MVP) cans Penthrox clinical trials in China

Medical Developments International (ASXLMVP) has scrapped plans for clinical trials of its Penthrox drug in China.

18 Jan 2023 11:47 (AEDT)



(20min delay)
Last
45.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $38.83M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 13239 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
51.0¢ 2000 1
View Market Depth
Last trade - 08.50am 03/05/2024 (20 minute delay) ?
MVP (ASX) Chart

Top Stories

Carnarvon revs up for revised Dorado Development

The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.